Previous studies have shown that LPS-activated microglia exhibit increased GLT-1 expression and glutamate uptake capacity in a TNFα-dependent manner [31], suggesting that microglia-mediated changes in glutamate uptake might be associated with clinical symptoms of HD. The gene discussed is SLC1A2; the disease is Huntington disease.